Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JOYY
2201
JOYY Inc
JOYY
$3.71B
| $2.79M | ﹤0.01% |
46,660
-886
| -2% | -$57.7K |
|
2202
Guardant Health
GH
$21.7B
| $2.79M | ﹤0.01% |
+74,098
| New | +$2.73M |
|
|
FOCS
2203
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.77M | ﹤0.01% |
105,393
-428
| -0.4% | -$14.9K |
|
2204
Coherus Oncology
CHRS
$217M
| $2.74M | ﹤0.01% |
302,840
+229
| +0.1% | +$2.65K |
|
2205
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.33B
| $2.74M | ﹤0.01% |
99,207
-1,845
| -2% | -$50K |
|
2206
Liberty Media Series A
FWONA
$22.5B
| $2.73M | ﹤0.01% |
96,007
+7,044
| +8% | +$208K |
|
|
VBTX
2207
DELISTED
Veritex Holdings
VBTX
| $2.72M | ﹤0.01% |
127,101
-1,174
| -0.9% | -$28.7K |
|
2208
Natera
NTRA
$38.3B
| $2.69M | ﹤0.01% |
192,912
-1,910
| -1% | -$34.9K |
|
|
FFWM
2209
DELISTED
First Foundation Inc
FFWM
| $2.69M | ﹤0.01% |
209,173
+2,278
| +1% | +$34.4K |
|
|
PFC
2210
DELISTED
Premier Financial Corp. Common Stock
PFC
| $2.69M | ﹤0.01% |
109,635
-752
| -0.7% | -$20.3K |
|
2211
Equity Bancshares
EQBK
$1.04B
| $2.68M | ﹤0.01% |
76,107
-73
| -0.1% | -$2.66K |
|
|
KREF
2212
KKR Real Estate Finance Trust
KREF
$448M
| $2.68M | ﹤0.01% |
139,778
+2,517
| +2% | +$49.6K |
|
2213
CEVA Inc
CEVA
$910M
| $2.67M | ﹤0.01% |
120,976
-276
| -0.2% | -$6.9K |
|
2214
Appian
APPN
$1.98B
| $2.66M | ﹤0.01% |
99,644
+10,188
| +11% | +$272K |
|
2215
Vipshop
VIPS
$7.37B
| $2.66M | ﹤0.01% |
486,569
-14,157
| -3% | -$76.2K |
|
2216
ADT
ADT
$5.58B
| $2.65M | ﹤0.01% |
441,340
+30,179
| +7% | +$227K |
|
|
FLIC
2217
DELISTED
First of Long Island Corp
FLIC
| $2.64M | ﹤0.01% |
132,254
-4,496
| -3% | -$92.4K |
|
|
DHIL
2218
DELISTED
Diamond Hill
DHIL
| $2.63M | ﹤0.01% |
17,598
-293
| -2% | -$48.6K |
|
2219
Assembly Biosciences
ASMB
$498M
| $2.63M | ﹤0.01% |
9,685
+124
| +1% | +$35.9K |
|
|
SMTA
2220
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
| $2.63M | ﹤0.01% |
368,683
+11,579
| +3% | +$117K |
|
|
ALTA
2221
DELISTED
Altabancorp
ALTA
| $2.62M | ﹤0.01% |
86,998
+28
| +0% | +$893 |
|
2222
Elastic
ESTC
$6.84B
| $2.62M | ﹤0.01% |
+36,577
| New | +$2.48M |
|
|
LABL
2223
DELISTED
Multi-Color Corp
LABL
| $2.62M | ﹤0.01% |
74,515
-504
| -0.7% | -$23.9K |
|
2224
Accuray
ARAY
$32M
| $2.61M | ﹤0.01% |
764,176
-5,156
| -0.7% | -$20.9K |
|
2225
Anika Therapeutics
ANIK
$258M
| $2.6M | ﹤0.01% |
77,397
-4,946
| -6% | -$179K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.